Stable recombinant expression and characterization of the two haemophilic factor VIII variants C329S (CRM-) and G1948D (CRMr)

被引:5
作者
David, D
Saenko, EL
Santos, IMA
Johnson, DJD
Tuddenham, EGD
McVey, JH
Kemball-Cook, G
机构
[1] Imperial Coll, Sch Med, MRC, Ctr Clin Sci, London W12 0NN, England
[2] Inst Nacl Saude Dr Ricardo Jorge, Ctr Human Genet, Lisbon, Portugal
[3] Amer Res Cross, Rockville, MD USA
基金
英国医学研究理事会;
关键词
factor VIII; haemophilia; recombinant; expression; immunofluorescence;
D O I
10.1046/j.1365-2141.2001.02399.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In haemophilia A, the functional defect at the molecular level of most factor VIII (FVIII) missense mutations remains unknown. Site-directed mutagenesis of B domain-deleted FVIII cDNA (FVIIISQ) was used to introduce two mutations associated with severe crossreacting material (CRM)-negative (FVIII-C329S) or mild/moderate CRM-reduced (FVIII-G1948D) haemophilia A. Wild-type (FVIIISQ-WT) and variant FVIIISQ proteins were successfully expressed after stable transfection in Chinese hamster ovary (CHO) cells, and partially characterized at the intracellular, molecular and functional levels. Reverse transcription polymerase chain reaction analysis confirmed that both transcription and mRNA processing appeared normal in CHO cells transfected with both the wild-type and two variant constructs. In contrast to FVIISQ-WT, immunofluorescence analysis of both CRM- and CRMr variants showed intracellular FVIII accumulation within the rough endoplasmic reticulum, suggesting secretion defects in transfected CHO cells, Immunoblot analysis of the FVIIISQ variant proteins that were secreted showed that they were expressed as mixed populations of uncleaved 170 kDa polypeptides, processed 90 kDa heavy chains and 80 kDa light chains, similar to FVIIISQ-WT. Phenotypic analysis of the B domain-deleted FVIIISQ variants expressed in CHO cells correlated well with the patients' reduced FVIII activity and, in addition, surface plasmon resonance studies demonstrated that both missense mutations were associated with increased rates of A2 domain dissociation following thrombin activation. We conclude that the mutations found are responsible for the haemophilia A phenotype, through intracellular retention and decreased stability of the active cofactor FVIIIa.
引用
收藏
页码:604 / 615
页数:12
相关论文
共 32 条
[1]  
Berntorp E, 1997, THROMB HAEMOSTASIS, V78, P256
[2]  
CLAXTON DF, 1994, BLOOD, V83, P1750
[3]   ANALYSIS OF THE ESSENTIAL SEQUENCES OF THE FACTOR-VIII GENE IN 12 HEMOPHILIA-A PATIENTS BY SINGLE-STRANDED CONFORMATION POLYMORPHISM [J].
DAVID, D ;
MOREIRA, I ;
LALLOZ, MRA ;
ROSA, HAV ;
SCHWAAB, R ;
MORAIS, S ;
DINIZ, MJ ;
DEDEUS, G ;
CAMPOS, M ;
LAVINHA, J ;
JOHNSON, D ;
TUDDENHAM, EGD .
BLOOD COAGULATION & FIBRINOLYSIS, 1994, 5 (02) :257-264
[4]  
DAVID D, 1995, HUM GENET, V95, P109
[5]   CONSTRUCTION AND CHARACTERIZATION OF AN ACTIVE FACTOR-VIII VARIANT LACKING THE CENTRAL 1/3 OF THE MOLECULE [J].
EATON, DL ;
WOOD, WI ;
EATON, D ;
HASS, PE ;
HOLLINGSHEAD, P ;
WION, K ;
MATHER, J ;
LAWN, RM ;
VEHAR, GA ;
GORMAN, C .
BIOCHEMISTRY, 1986, 25 (26) :8343-8347
[6]   MONOCLONAL-ANTIBODIES TO FACTOR-VIII - THEIR APPLICATION IN IMMUNOBLOTTING FOR THE VISUALIZATION OF FACTOR-VIII IN THERAPEUTIC CONCENTRATES AND PLASMA [J].
FURLONG, RA ;
WELCH, AN ;
PEAKE, IR .
BRITISH JOURNAL OF HAEMATOLOGY, 1987, 66 (03) :341-348
[7]  
KAUFMAN RJ, 1988, J BIOL CHEM, V263, P6352
[8]   Diagnostic importance of the two-stage factor VIII:C assay demonstrated by a case of mild haemophilia associated with His1954 → Leu substitution in the factor VIII A3 domain [J].
Keeling, DM ;
Sukhu, K ;
Kemball-Cook, G ;
Waseem, N ;
Bagnall, R ;
Lloyd, JV .
BRITISH JOURNAL OF HAEMATOLOGY, 1999, 105 (04) :1123-1126
[9]   HIGH-LEVEL PRODUCTION OF HUMAN BLOOD-COAGULATION FACTOR-VII AND FACTOR-XI USING A NEW MAMMALIAN EXPRESSION VECTOR [J].
KEMBALLCOOK, G ;
GARNER, I ;
IMANAKA, Y ;
NISHIMURA, T ;
OBRIEN, DP ;
TUDDENHAM, EGD ;
MCVEY, JH .
GENE, 1994, 139 (02) :275-279
[10]   THE BEHAVIOR OF DIFFERENT FACTOR-VIII CONCENTRATES IN A CHROMOGENIC FACTOR X-ACTIVATING SYSTEM [J].
KEMBALLCOOK, G ;
TUBBS, JE ;
DAWSON, NJ ;
BARROWCLIFFE, TW .
BRITISH JOURNAL OF HAEMATOLOGY, 1993, 84 (02) :273-278